National survey on the secondary preventive measures for coronary artery disease among interventional cardiologists: a report from the Japanese Association of Cardiovascular Intervention and Therapeutics.
Cardiac rehabilitation
Coronary artery disease
Interventionist
Secondary prevention
Journal
Cardiovascular intervention and therapeutics
ISSN: 1868-4297
Titre abrégé: Cardiovasc Interv Ther
Pays: Japan
ID NLM: 101522043
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
01
04
2022
accepted:
18
06
2022
pubmed:
15
7
2022
medline:
6
1
2023
entrez:
14
7
2022
Statut:
ppublish
Résumé
Insights from recent clinical trial testing revascularization strategies have interested interventional cardiologists in optimal medical therapy and secondary prevention modalities. As no large-scale survey has been recently conducted, this report presents the results of a nationwide survey on interventionists' concerns regarding secondary prevention after percutaneous coronary intervention (PCI) and discusses medical support system needs in Japan. A questionnaire to assess the status and challenges of secondary prevention interventions by interventional cardiologists during outpatient visits was supplied to Cardiovascular Interventional Technology (CVIT)-certificated hospitals. This was answered by representative cardiologists of each hospital and comprised three queries: (1) the necessity of outpatient cardiac rehabilitation to promote post-PCI lifestyle guidance; (2) the feasibility of providing lifestyle guidance; and (3) the barriers to lifestyle guidance, during outpatient visits. Questions 1 and 2 were answered using a 5-point Likert scale. Survey responses were received from 391 hospitals (54.9% of 712 CVIT-certificated facilities). For Question 1, 327 hospitals (84.1%) answered "agree", and 386 hospitals (98.7%) answered "agree" or "somewhat agree". For Question 2, 10% of hospitals answered "agree", and "agree" and "somewhat agree" amounted to less than 50%. For Question 3, 83.5% of the facilities answered lack of time as the major reason). The next reasons included an early reverse referral to family doctors after PCI, and a lack of managerial advantage (60% and 40% of the hospitals, respectively). In conclusion, interventionists are concerned about secondary prevention for their patients. The issues clarified in the survey will be important for developing next-generation secondary prevention systems.
Identifiants
pubmed: 35834169
doi: 10.1007/s12928-022-00874-y
pii: 10.1007/s12928-022-00874-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
49-54Subventions
Organisme : AMED
ID : JP21le0110020
Informations de copyright
© 2022. The Author(s) under exclusive licence to Japanese Association of Cardiovascular Intervention and Therapeutics.
Références
Brown DL. Optimal medical therapy as first-line therapy for chronic coronary syndromes: lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA. Cardiovasc Drugs Ther. 2021. https://doi.org/10.1007/s10557-021-07289-6 .
doi: 10.1007/s10557-021-07289-6
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, et al. Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2019;393:2503–10.
doi: 10.1016/S0140-6736(19)30474-X
Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16. https://doi.org/10.1056/NEJMoa070829 .
doi: 10.1056/NEJMoa070829
BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503–15. https://doi.org/10.1056/NEJMoa0805796 .
doi: 10.1056/NEJMoa0805796
Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, et al. Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med. 2018;379:250–9.
doi: 10.1056/NEJMoa1803538
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382:1395–407.
doi: 10.1056/NEJMoa1915922
Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac rehabilitation for coronary heart disease Cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67:1–12.
doi: 10.1016/j.jacc.2015.10.044
Japanese Circulation Society. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome [Internet]. 2018. Available from https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2018_kimura.pdf
Japanese Circulation Society. JCS 2018 guideline on diagnosis of chronic coronary heart diseases. 2018; Available from https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2018_yamagishi_tamaki.pdf
Kanazawa N, Yamada S, Fushimi K. Trends in the use of cardiac rehabilitation in Japan between 2010 and 2017—an epidemiological survey. Circ Rep. 2021;3:569–77.
doi: 10.1253/circrep.CR-21-0018
Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92:1150–4.
doi: 10.1016/j.amjcard.2003.07.021
Okura N, Ogawa H, Katoh J, Yamauchi T, Hagiwara N. Long-term prognosis of patients with acute myocardial infarction in the era of acute revascularization (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] registry). Int J Cardiol. 2012;159:205–10. https://doi.org/10.1016/j.ijcard.2011.02.072 .
doi: 10.1016/j.ijcard.2011.02.072
Sawano M, Kohsaka S, Ishii H, Numasawa Y, Yamaji K, Inohara T, et al. One-year outcome after percutaneous coronary intervention for acute coronary syndrome—an analysis of 20,042 patients from a Japanese nationwide registry. Circ J. 2021;85:1756–67.
doi: 10.1253/circj.CJ-21-0098
Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher registry. Circulation. 2012;125:584–91.
doi: 10.1161/CIRCULATIONAHA.111.046599
Pandey AC, Golbus JR, Topol EJ. Cardiac rehabilitation in the digital era. Lancet. 2021;398:16. https://doi.org/10.1016/S0140-6736(21)01437-9 .
doi: 10.1016/S0140-6736(21)01437-9
Ramachandran HJ, Jiang Y, Tam WWS, Yeo TJ, Wang W. Effectiveness of home-based cardiac telerehabilitation as an alternative to Phase 2 cardiac rehabilitation of coronary heart disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2021;29:1–27.
Kikuchi A, Taniguchi T, Nakamoto K, Sera F, Ohtani T, Yamada T, et al. Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: a pilot study. J Cardiol. 2021;78:66–71. https://doi.org/10.1016/j.jjcc.2021.01.010 .
doi: 10.1016/j.jjcc.2021.01.010
Itoh H, Amiya E, Narita K, Shimbo M, Taya M, Komuro I, et al. Efficacy and safety of remote cardiac rehabilitation in the recovery phase of cardiovascular diseases: protocol for a multicenter, nonrandomized, single-arm, interventional trial. JMIR Res Protoc 2021;10.
Huang K, Liu W, He D, Huang B, Xiao D, Peng Y, et al. Telehealth interventions versus center-based cardiac rehabilitation of coronary artery disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2015;22:959–71.
doi: 10.1177/2047487314561168